Home / Markets / TARS / Balance Sheet ← All companies T Tarsus Pharmaceuticals, Inc. TARS - CIK 0001819790
Overview Market Cap Revenue Net Income Income Statement Balance Sheet Cash Flow SEC Filings TARS balance sheet (quarterly) The table below shows Tarsus Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item Q1 2026 Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Cash & equivalents $102.19M $112.72M $96.65M $175.79M $176.21M $181.09M Short-term investments $286.54M $289.11M $284.50M $232.13M $140.74M $142.49M Receivables $100.34M $72.62M $58.33M $62.43M $29.16M $29.53M Inventory $4.57M $3.84M $3.87M $2.71M $2.85M $2.19M
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings .